Heart Valve Technology

This channel includes news and new device innovations about heart valve technologies, including the aortic valve, mitral valve, pulmonic valve, and tricuspid valve. This includes information on transcatheter valve technologies like transcatheter aortic valve replacement (TAVR, or implantation TAVI), transcatheter mitral valve replacement (TMVR), transcatheter and surgical valve repairs, ad surgical replacement valves.

This shows the TEE ultrasound imaging used to guide MitraClip procedures to treat functional mitral regurgitation.

360 Photos | 360 View Photos | April 12, 2019

360 View of the TEE Echo Workstation During a MitraClip Procedure

This 360 degree view shows staff at the...

News | Heart Valve Technology | April 08, 2019 | Jeff Zagoudis, Associate Editor

Mick Jagger Recovering After TAVR Procedure

April 8, 2019 — Rolling Stones frontman Mick Jagger is reportedly recovering after undergoing a...

Evolut Low Risk Trial compared the minimally invasive Evolut transcatheter aortic valve replacement (TAVR) system to the gold standard of open-heart surgery in characteristically younger, healthier aortic stenosis patients. The randomized trial, which met its primary non-inferiority endpoint of all-cause mortality or disabling stroke at two years compared to surgery (5.3 vs. 6.7 percent; posterior probability of non-inferiority >0.999), was presented at the American College of Cardiology (ACC) 2019 meeting

News | Heart Valve Technology | April 03, 2019

TAVR Performs Well Compared to Surgical Aortic Valve Replacement in Low Risk Patients

April 3, 2019 – The ACC.19 late-breaking landmark Evolut Low Risk Trial compared the minimally invasive Evolut...

Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore Manta Vascular Closure Device. It is designed to close large puncture sites in the femoral artery from larger sized transcatheter devices, including the Impella heart pump, endovascular stent grafts and transcatheter valves.

Technology | Vascular Closure Devices | April 03, 2019

Large-Bore Vascular Closure Device Cleared by the FDA

April 3, 2019 — Essential Medical Inc. received U.S. Food and Drug Administration (FDA) clearance for its large bore...

All major vendors offering advanced visualization software now offer structural heart planning. This is an example of GE Healthcare's Valve Assist software being used to determine the best location of a transseptal puncture to deliver a left atrial appendage (LAA) occluder.

All major vendors offering advanced visualization software now offer structural heart planning. This is an example of GE Healthcare's Valve Assist software being used to determine the best location of a transseptal puncture to deliver a left atrial appendage (LAA) occluder.

Feature | Structural Heart | March 28, 2019 | Jeff Zagoudis

The Essentials of Structural Heart Imaging

Structural heart interventions represent one of the fastest growing segments of cardiology, as the number of devices...

Videos | March 28, 2019

VIDEO: The Role of the NCDR in Boosting Cardiology Quality Improvement

Interview with Frederick Masoudi, M....

Videos | Heart Valve Technology | March 27, 2019

VIDEO: Transcatheter Mitral Valve Interventions at Henry Ford Hospital

Marvin Eng, M.D.,...

The Centers for Medicare and Medicaid Services (CMS) proposed to update its national coverage policy for transcatheter aortic valve replacement (TAVR). The current national coverage determination, effective May 1, 2012, established CMS coverage for TAVR under Coverage with Evidence Development (CED). Since the finalization of the 2012 national coverage determination, TAVR programs have been established in more than 500 hospitals across the country.

News | Heart Valve Technology | March 27, 2019

CMS Proposes Updates for TAVR Coverage

March 27, 2019 — The Centers for Medicare and Medicaid Services (CMS...

News | Heart Valve Technology | March 22, 2019

TAVR Outperforms Surgery in Younger, Low-Risk Aortic Stenosis Patients

March 22, 2019 — Among patients with severe symptomatic aortic stenosis at low surgical risk,...

News | Cardiovascular Ultrasound | March 21, 2019

Echocardiograms May Help With Patient Selection for Transcatheter Mitral Valve Repair

March 21, 2019 — Clinicians should use...

News | Heart Valve Technology | March 14, 2019

ACC Launches Transcatheter Valve Certification

March 14, 2019 — Beginning in mid-2019, hospitals performing...

Feature | Heart Valve Technology | March 14, 2019 | Jeff Zagoudis, Associate Editor

FDA Approves MitraClip for Use in Heart Failure Patients With Functional Mitral Regurgitation

March 14, 2019 — The U.S. Food and Drug Administration (FDA) approved the MitraClip...

News | Heart Valve Technology | March 07, 2019

Transcatheter Pulmonary Valve Therapy Market Poised for Growth

March 7, 2019 — Rising incidence of ...

Scientists Discover New Type of Immune Cells Essential for Forming Heart Valves

Microscopic images of a normal heart valve in a mouse, left, and a heart valve grown in a lab with heart-derived macrophages blocked, right. Without those macrophages, the valves are thick and deformed. Image courtesy of Developmental Cell/UCLA Broad Stem Cell Research Center.

News | Heart Valve Technology | March 06, 2019

Scientists Discover New Type of Immune Cells Essential for Forming Heart Valves

March 6, 2019 — UCLA researchers have identified for the first time the origin of an immune cell that plays a...

News | Heart Valve Technology | March 01, 2019

Global Market for Transcatheter Treatments to Double in Next Five Years

March 1, 2019 — When it comes to treatment options for a damaged...

‹ previous
1
2
3
4
5
6
7
8
9
…
next ›